CISLEUKIN

Welcome to the Brand page for “CISLEUKIN”, which is offered here for Research and development of therapeutic antibodies and pharmaceuticals, and research and development of technology in the field of therapeutic antibodies and pharmaceuticals;.

Its status is currently believed to be active. Its class is unavailable. “CISLEUKIN” is believed to be currently owned by “INHIBRX, INC.”


Owner:
INHIBRX, INC.
Owner Details
Description:
Research and development of therapeutic antibodies and pharmaceuticals, and research and development of technology in the field of therapeutic antibodies and pharmaceuticals;
Categories: RESEARCH DEVELOPMENT THERAPEUTIC